Urinary and Urethral Microbiota #18

IDIOPATHIC URETHRITIS IN MEN: NEW INFECTIOUS ETIOLOGIES?

^{Plummer EL, Ratten LK, Vodstrcil LA, et al. The urethral microbiota of men with and without idiopathic urethritis. mBio 2022; 13: e0221322.}

Some Australian researchers sought to determine which infectious agents, apart from those already known, might contribute to non-gonococcal urethritis in men, taking into account their sexual practices and the biological sex of their partner. For this, they conducted a case study including 199 men, 96 of whom had symptoms of idiopathic urethritis and 103 of whom did not, who served as controls. The median age of participants was 31 years, 73 had had a sexual relationship with a man in the month prior to inclusion (classified as MSM), and the remainder were classified as MSW. For all of them, the researchers had samples of urinary and urethral microbiota available for sequencing analysis. Their results revealed that Haemophilus influenzae, which naturally colonizes nasopharyngeal microbiota, was more abundant in MSM participants with idiopathic urethritis. In addition, H. influenzae was clearly associated with clinical features such as urethral burning, dysuria and purulent discharge. The researchers believe having oral sex without a condom could be the main mode of contamination by this bacterium. They observed more of the genus Corynebacterium in affected MSW, which they found surprising since it is considered commensal in male genital microbiota. The scientists conclude that some specific species of Corynebacterium may become pathogenic when present in abundance. There were also more Ureaplasma, Staphylococcus haemolyticus, Streptococcus pyogenes, Escherichia and Streptococcus pneumoniae in the urinary and urethral microbiota of symptomatic subjects, so they may all promote urethritis. Possible infectious causes of non-gonococcal urethritis, previously described as idiopathic, have thus been discovered. If these results are confirmed by other studies, doctors may eventually be able to offer their patients more targeted treatments.